A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...

China: A new meta-analysis published in Annals of Medicine has identified elevated C-reactive protein (CRP) levels as a ...

Medicus Pharma offers high-risk, high-reward potential, with its novel SkinJect patch for basal cell carcinoma and Antev ...

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by ...

TIL-IMP therapy offers sustained QoL benefits over ipilimumab in advanced melanoma, supporting its role in personalized care.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Researchers have discovered that the most aggressive melanomas, the deadliest form of skin cancer, overactivate two key ...

A new study explores a one-and-done radiotherapy for non-melanoma skin cancer – no scalpels, no stitches, just science.

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...